|
| Press Releases |
|
 |
|
| Tuesday, June 6, 2017 |
|
|
山东罗欣药业H股于联交所买卖于2017年6月6日起暂停直至于2017年6月16日撤销上市 |
| 山东罗欣药业集团股份有限公司（「山东罗欣药业」或「集团」）（股份代号：8058）宣布其H股于联交所买卖于今日起暂停，并将继续暂停买卖直至于2017年6月16日上午九时正在联交所撤销上市为止。 more info >> |
|
|
山東羅欣藥業H股於聯交所買賣於2017年6月6日起暫停直至於2017年6月16日撤銷上市 |
山東羅欣藥業集團股份有限公司（「山東羅欣藥業」或「集團」）（股份代號：8058）宣佈其H股於聯交所買賣於今日起暫停，並將繼續暫停買賣直至於2017年6月16日上午九時正在聯交所撤銷上市為止。
more info >> |
|
|
Shandong Luoxin Pharmaceutical's H Shares Trading is Suspended from 6 June 2017 until its Delisting on 16 June 2017 |
| Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. ("Shandong Luoxin Pharmaceutical" or the "Company") (stock code: 8058) has announced that the trading in its H Shares has been suspended from today and will remain suspended until the withdrawal of listing of the H Shares from the Stock Exchange from 9:00 a.m. on 16 June 2017. more info >> |
|
| Wednesday, May 31, 2017 |
|
|
山东罗欣药业获股东批准撤销H股在联交所的上市地位 要约在各方面成为无条件 |
| 山东罗欣药业集团股份有限公司（「山东罗欣药业」或「集团」）（股份代号：8058）公布于2017年5月29日股东特别大会及H股类别股东大会上，以投票方式通过撤销集团H股（「H股」）在香港联合交易所有限公司（「联交所」）之上市地位。 more info >> |
|
|
山東羅欣藥業獲股東批准撤銷H股在聯交所的上市地位 要約在各方面成為無條件 |
| 山東羅欣藥業集團股份有限公司（「山東羅欣藥業」或「集團」）（股份代號：8058）公佈於2017年5月29日股東特別大會及H股類別股東大會上，以投票方式通過撤銷集團H股（「H股」）在香港聯合交易所有限公司（「聯交所」）之上市地位。 more info >> |
|
|
Shandong Luoxin Pharmaceutical's Withdrawal of Listing H Shares on HKEx Approved by Shareholders; Offer becomes Unconditional in All Respects |
| Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. ("Shandong Luoxin Pharmaceutical" or the "Company") (stock code: 8058) has announced that the resolution for the proposed withdrawal of listing of the H shares of the Company more info >> |
|
| Tuesday, April 11, 2017 |
|
|
山东罗欣药业获自愿有条件要约 |
| 山东罗欣药业集团股份有限公司（「山东罗欣药业」或「集团」）（股份代号：8058）公布，Giant Star Global (HK) Limited（「Giant Star HK」）及Ally Bridge Flagship LX ( HK) Limited（「Ally Bridge Flagship」）（「联合要约人」）就集团之全部已发行H股 more info >> |
|
|
山東羅欣藥業獲自願有條件要約 |
| 山東羅欣藥業集團股份有限公司（「山東羅欣藥業」或「集團」）（股份代號：8058）公佈，Giant Star Global (HK) Limited（「Giant Star HK」）及 Ally Bridge Flagship LX (HK) Limited（「Ally Bridge Flagship」）（「聯合要約人」）就集團之全部已發行H股 more info >> |
|
|
Shandong Luoxin Pharmaceutical Receives a Voluntary Conditional Offer |
| Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. ("Shandong Luoxin" or the "Group") (stock code: 8058) has announced that Giant Star Global (HK) Limited ("Giant Star HK") and Ally Bridge Flagship LX (HK) Limited ("Ally Bridge Flagship") ("Joint Offerors") have extended a voluntary conditional offer (the "Offer") for all the issued H shares in Shandong Luoxin (other than those already owned more info >> |
|
| Wednesday, May 8, 2013 |
|
|
罗欣药业公布2013年第一季度业绩 |
| 中国领先现代制药企业 ─ 山东罗欣药业股份有限公司（「罗欣药业」或「公司」，股份编号：8058）今天宣布截至2013年3月31日止3个月（「回顾期」）未经审核之第一季度业绩。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
CleverTap Recognized as a 'Strong Performer' in the Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 23, 2024 20:42 HKT/SGT
|
|
|
First Quarterly Profit, High-Quality Platform Growth, NaaS Technology Accelerates Ecosystem Development
Nov 22, 2024 23:22 HKT/SGT
|
|
|
Tat Hong Equipment Service Co., Ltd. Announces 2024/25 Interim Results
Nov 22, 2024 19:56 HKT/SGT
|
|
|
达丰设备服务有限公司 公布2024/25中期业绩
Nov 22, 2024 19:35 HKT/SGT
|
|
|
達豐設備服務有限公司 公佈2024/25中期業績
Nov 22, 2024 19:18 HKT/SGT
|
|
|
透雲生物萊茵衣藻獲國家衛健委新用途許可
Nov 22, 2024 14:42 HKT/SGT
|
|
|
透云生物莱茵衣藻获国家卫健委新用途许可
Nov 22, 2024 14:41 HKT/SGT
|
|
|
Daeshin MC Co., Ltd. Unveils Its Clean Solutions Creating Pleasant Indoor Environments from Industrial Sites to Public Facilities
Nov 22, 2024 12:00: JST
|
|
|
Daeshin MC Co., Ltd.は、産業現場から公共施設まで快適な室内環境を作り出すクリーンソリューションを発表
Nov 22, 2024 12:00: JST
|
|
|
三菱重工、新たな防衛輸送用「機動舟艇」に搭載するウォータージェット推進装置の供給へ
Nov 22, 2024 11:45: JST
|
|
|
Daeshin MC Co., Ltd. Unveils Its Clean Solutions Creating Pleasant Indoor Environments from Industrial Sites to Public Facilities
Nov 22, 2024 11:00 HKT/SGT
|
|
|
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Nov 22, 2024 11:00 JST
|
|
|
Jacobson Pharma Announces FY2025 Interim Results
Nov 22, 2024 10:00 HKT/SGT
|
|
|
雅各臣公佈二零二五財年中期業績 持續經營業務溢利飈升44.2%
Nov 22, 2024 10:00 HKT/SGT
|
|
|
アレス・マネジメント、東京オフィス開設でアジア事業を拡充
Nov 22, 2024 09:00: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
